MNKD MannKind Corp
Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Biotechnology > Biotechnology | NASDAQ, SmallCap | Last Price: 2.84 | 2026-04-17 | Atrp: 5.22
Sun 12 Apr 2026 to Sat 18 Apr 2026: Score -19
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 2.99 | 4.39 | ▲ 46.82% | Bearish. Lower is better. Significant decline |
| â | Short Percent | 7.48% | 9.67% | ▲ 29.28% | Bearish. Lower is better. Significant increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | EPS Estimate Next Year | 0.2275 | 0.2 | ▼ -12.09% | Bearish. Higher is better. Moderate lowered expectations for further out Expected earnings per share next year |
| â | Price Sales TTM | 2.2742 | 2.5131 | ▲ 10.5% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Forward PE | 256.4103 | 277.7778 | ▲ 8.33% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Enterprise Value/Revenue | 2.8361 | 2.9954 | ▲ 5.62% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 19.2126 | 20.2916 | ▲ 5.62% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Wall Street Target Price | 7.3889 | 7.1667 | ▼ -3.01% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | Enterprise Value | $0.99B | $1.05B | ▲ 5.62% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sun 05 Apr 2026 to Sun 12 Apr 2026: Score -4
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Wall Street Target Price | 7.5 | 7.3889 | ▼ -1.48% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | Forward PE | 250 | 256.4103 | ▲ 2.56% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.2072 | 2.2742 | ▲ 3.04% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value/Revenue | 2.7559 | 2.8361 | ▲ 2.91% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 18.6695 | 19.2126 | ▲ 2.91% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value | $0.96B | $0.99B | ▲ 2.91% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sun 29 Mar 2026 to Sun 05 Apr 2026: Score -2
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Price Sales TTM | 2.013 | 2.2072 | ▲ 9.65% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
Mon 16 Mar 2026 to Sun 29 Mar 2026: Score 15
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 4.34 | 2.99 | ▼ -31.11% | Bullish. Lower is better. Significant improvement |
| â | Forward PE | 277.7778 | 250 | ▼ -10% | Bullish. Lower is better. Moderate improvement Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.4456 | 2.013 | ▼ -17.69% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Short Percent | 8.43% | 7.48% | ▼ -11.27% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Enterprise Value/Revenue | 3.0075 | 2.7427 | ▼ -8.8% | Bullish. Lower is better. Slight improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 20.3741 | 18.5798 | ▼ -8.81% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value | $1.05B | $0.96B | ▼ -8.81% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sun 08 Mar 2026 to Mon 16 Mar 2026: Score -1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Forward PE | 263.1579 | 277.7778 | ▲ 5.56% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.3044 | 2.4456 | ▲ 6.13% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value/Revenue | 2.8663 | 3.0075 | ▲ 4.93% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 19.4172 | 20.3741 | ▲ 4.93% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Percent | 8.66% | 8.43% | ▼ -2.66% | Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Enterprise Value | $1B | $1.05B | ▲ 4.93% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Short Ratio | 6.97 | 4.34 | ▼ -37.73% | Bullish. Lower is better. Significant improvement |
Fri 27 Feb 2026 to Sun 08 Mar 2026: Score -30
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | PEG Ratio | -0.23 | 4.3866 | ▲ 2007.22% | Bearish. Lower is better. Extreme increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 34.3643 | 263.1579 | ▲ 665.79% | Bearish. Lower is better. Extreme decline Stock price divided by expected future earnings |
| â | Earnings Per Share | 0.1 | 0.02 | ▼ -80% | Bearish. Higher is better. Substantial decline in earnings per share Profit allocated to each outstanding share |
| â | Profit Margin | 9.32% | 1.68% | ▼ -81.97% | Bearish. Higher is better. Profit margin growth slowing. Percentage of revenue that turns into profit |
| â | Operating Margin TTM | 22.86% | -6.87% | ▼ -130.05% | Bearish. Higher is better. Operating margin TTM turned from growth to decline; signs of deterioration. Percentage of revenue left after operating expenses |
| â | EBITDA | $84.72M | $58.83M | ▼ -30.55% | Bearish. Higher is better. Decline in earnings before interest, taxes, depreciation, and amortization; indicates weaker operational cash flow Earnings before interest, taxes, depreciation, and amortization |
| â | EPS Estimate Current Year | 0.1325 | 0.0967 | ▼ -27.02% | Bearish. Higher is better. Significant decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | Return On Assets TTM | 9.95% | 4.91% | ▼ -50.65% | Bearish. Higher is better. Return on assets TTM growth slowing. Efficiency in generating profits from total assets |
| â | Enterprise Value | $1.55B | $1B | ▼ -35.57% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Wall Street Target Price | 9.0556 | 7.5 | ▼ -17.18% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | Book Value | -0.145 | -0.166 | ▼ -14.48% | Bearish. Higher is better. Moderate decrease; stock now trades further from book value Net asset value of the company per share |
| â | EPS Estimate Next Year | 0.25 | 0.2275 | ▼ -9% | Bearish. Higher is better. Slight lowered expectations for further out Expected earnings per share next year |
| â | Enterprise Value/EBITDA | 19.6238 | 19.4172 | ▼ -1.05% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Gross Profit TTM | $235.9M | $261.01M | ▲ 10.64% | Bullish. Higher is better. Moderate increase, but margins may be improving Revenue minus cost of goods sold over the trailing twelve months |
| â | Revenue TTM | $313.79M | $348.97M | ▲ 11.21% | Bullish. Higher is better. Moderate top-line expansion Total revenue over the trailing twelve months |
| â | Revenue Per Share TTM | 1.051 | 1.272 | ▲ 21.03% | Bullish. Higher is better. Significant improvement Revenue generated per outstanding share over the trailing twelve months |
| â | Price Sales TTM | 3.1706 | 2.3044 | ▼ -27.32% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value/Revenue | 5.1446 | 2.8663 | ▼ -44.29% | Bullish. Lower is better. Significant improvement Enterprise value divided by revenue |
| â | Quarterly Revenue Growth YOY | 171% | 461% | ▲ 166.28% | Bullish. Higher is better. Quarterly revenue growth YOY growth accelerating. Year-over-year growth in quarterly revenue |
Wed 11 Feb 2026 to Fri 27 Feb 2026: Score -4
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Enterprise Value/Revenue | 2.9541 | 5.1446 | ▲ 74.15% | Bearish. Lower is better. Substantial decline Enterprise value divided by revenue |
| â | EPS Estimate Current Year | 0.1933 | 0.1325 | ▼ -31.45% | Bearish. Higher is better. Significant decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | Enterprise Value/EBITDA | 12.667 | 19.6238 | ▲ 54.92% | Bearish. Lower is better. Substantial decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Ratio | 5.18 | 6.97 | ▲ 34.56% | Bearish. Lower is better. Significant decline |
| â | Short Percent | 7.6% | 8.66% | ▲ 13.95% | Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Wall Street Target Price | 9.4375 | 9.0556 | ▼ -4.05% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | Price Sales TTM | 3.4251 | 3.1706 | ▼ -7.43% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Institutional Ownership | 55.148% | 59.609% | ▲ 8.09% | Bullish. Higher is better. Slight increase; continued strong interest from big investors Percentage held by institutions like mutual funds |
| â | Forward PE | 79.3651 | 34.3643 | ▼ -56.7% | Bullish. Lower is better. Substantial improvement Stock price divided by expected future earnings |
| â | EPS Estimate Next Year | 0.1467 | 0.25 | ▲ 70.42% | Bullish. Higher is better. Substantial raised expectations for further out Expected earnings per share next year |
| â | Enterprise Value | $0.93B | $1.55B | ▲ 67.47% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Wed 04 Feb 2026 to Wed 11 Feb 2026: Score 11
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Price Sales TTM | 5.6563 | 3.4251 | ▼ -39.45% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value/Revenue | 5.6403 | 2.9541 | ▼ -47.63% | Bullish. Lower is better. Significant improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 24.1856 | 12.667 | ▼ -47.63% | Bullish. Lower is better. Significant improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Forward PE | 88.4956 | 79.3651 | ▼ -10.32% | Bullish. Lower is better. Moderate improvement Stock price divided by expected future earnings |
| â | Enterprise Value | $1.71B | $0.93B | ▼ -45.65% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Wed 28 Jan 2026 to Wed 04 Feb 2026: Score -7
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Forward PE | 80 | 88.4956 | ▲ 10.62% | Bearish. Lower is better. Moderate decline Stock price divided by expected future earnings |
| â | Enterprise Value/EBITDA | 21.5 | 24.1856 | ▲ 12.49% | Bearish. Lower is better. Moderate decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value/Revenue | 5.1446 | 5.6403 | ▲ 9.64% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Price Sales TTM | 5.4703 | 5.6563 | ▲ 3.4% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value | $1.55B | $1.71B | ▲ 9.86% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Thu 13 Nov 2025 to Wed 28 Jan 2026: Score -2
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Enterprise Value | $1.57B | $1.55B | ▼ -1.33% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Enterprise Value/Revenue | 5.014 | 5.1446 | ▲ 2.6% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |